MedTrace Logo

Supporting Patients Starting New Medicines: Evaluating the myCare Start Service in Switzerland

NCT07036471 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1600

Last updated 2025-06-25

No results posted yet for this study

Summary

In Phase B, the aim is to evaluate the myCare Start service in routine care within the ambulatory primary care medicine and community pharmacy setting in Switzerland. A Type II hybrid effectiveness-implementation study will be conducted to evaluate the effectiveness (improvement in adherence), cost-effectiveness and implementation of the service. This evaluation will allow us to build the necessary contextual relevant evidence base to support sustainable funding of the service in the long term.

Conditions

  • Cardio-vascular Disease
  • Depression Disorders
  • Diabetes
  • COPD
  • Asthma Bronchiale
  • Hyperlipidaemia
  • Medication Initiation for Long-term Conditions

Interventions

BEHAVIORAL

myCare Start

The service consists of two 10-minute, semi-structured and tailored consultations delivered by community pharmacists during the first 6 weeks of a patient initiating a new long-term medication, followed by tailored feedback to the patient's physician.

Sponsors & Collaborators

  • University of Basel

    collaborator OTHER

  • pharmaSuisse

    collaborator UNKNOWN

  • Center for Primary Care and Public Health (Unisante), University of Lausanne, Switzerland

    collaborator OTHER

  • University of Bern

    collaborator OTHER

  • University of Geneva, Switzerland

    lead OTHER

Principal Investigators

  • Marie Paule Schneider, Prof. PhD · Uinversity of Geneva

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
SEQUENTIAL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-06-30
Primary Completion
2027-01-31
Completion
2027-01-31

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07036471 on ClinicalTrials.gov